Citation Impact
Citing Papers
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
2008 Science
Coexpression of NRASQ61R and BRAFV600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity
2006
Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
2009
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial
2008
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.
2008
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
Beta-catenin inhibits melanocyte migration but induces melanoma metastasis
2012
MYC on the Path to Cancer
2012 Standout
Analysis of the genome to personalize therapy for melanoma
2010
Can we safely target the WNT pathway?
2014
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Epigenetics: A Landscape Takes Shape
2007 Standout
Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Polycomb silencers control cell fate, development and cancer
2006
In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer
2010
Wnt signaling in cancer
2016 Standout
Cancer genetics of epigenetic genes
2007
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Roles of the EZH2 histone methyltransferase in cancer epigenetics
2008
SWI/SNF nucleosome remodellers and cancer
2011 Standout
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
2008
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Psoriasis
2021 Standout
Cancer stem cells revisited
2017 Standout
Polycomb group proteins: navigators of lineage pathways led astray in cancer
2009
Global Changes in the Mammary Epigenome Are Induced by Hormonal Cues and Coordinated by Ezh2
2013
MAP kinase signalling pathways in cancer
2007 Standout
In melanoma, beta-catenin is a suppressor of invasion
2011
EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin
2011
Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer
2012
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Immunohistochemical characteristics of melanoma
2008
Molecular Mechanisms of Long Noncoding RNAs
2011 Standout
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
2009
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
2010
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells
2008
Eicosanoids and cancer
2010 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Epigenetic modifications as therapeutic targets
2010
Histone Methyltransferase EZH2 Is Transcriptionally Induced by Estradiol as Well as Estrogenic Endocrine Disruptors Bisphenol-A and Diethylstilbestrol
2014
The cancer epigenome—components and functional correlates
2006
Epigenetic modifications and human disease
2010 Standout
Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
2014
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
2007 Standout
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
2010
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Wnt Signaling in Skin Development, Homeostasis, and Disease
2012
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
2010 StandoutNature
Histone methyltransferases in cancer
2009
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
2010 StandoutScience
Mutations in GNA11 in Uveal Melanoma
2010 Standout
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
2010
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Linking DNA methylation and histone modification: patterns and paradigms
2009 Standout
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
2011
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
2011
HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase
2017 StandoutNobel
Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy
2009
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics
2006
WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
2008
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
2013 Standout
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
2019 Standout
The Small GTPase ARF6 Stimulates β-Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis
2013
A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer
2007
BODIPY dyes in photodynamic therapy
2012 Standout
Causal analysis approaches in Ingenuity Pathway Analysis
2013 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy
2007
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
2015
Myc Enforces Overexpression ofEZH2in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
2011
Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAF V600E in Human Melanoma
2012
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
2009
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
2013 Standout
Enhancer of zeste homolog 2 ( EZH2 ) promotes tumour cell migration and invasion via epigenetic repression of E ‐cadherin in renal cell carcinoma
2014
Works of Ingeborg Bachmann being referenced
BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival
2005
Mutation analysis of the EGFR–NRAS–BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma
2008
Five-Year Follow-up of a Randomized, Prospective Trial of Topical Methyl Aminolevulinate Photodynamic Therapy vs Surgery for Nodular Basal Cell Carcinoma
2007
EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast
2005
Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma
2005
Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas
2004
Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter STEPI n study
2018